$230 Million Blank Check! As in blank.

Hats Off to Cantor and Northland Securities for Raising $230 Million to Invest in Something. Not Sure What, Just Something. Something...

Duos Technologies (DOUT) $0.70. Artificial Intelligence Made Easy. Grossly Undervalued.

Internet Stock Review Adds Duos Technologies ($0.70) to Watch List. Graduates to OTCQX 6/20/19. Duos Technologies Website. Presentation...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its...
Dr. Lindsay Rosenwald

Dr Lindsay Rosenwald, Biography.

Wall Street Transcript Interview (2018) IDB Bank Profile Biography (2011) LR Facts*, below. For...

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...

Bradley Rotter: Cybersecurity: AI, Friend or Foe?

Applied AI Conference 2017  https://youtu.be/VcNXvqdsKMI?si=Ze_a_LHMrkb-4ksk The Applied AI Conference is...
Roland Rick Perry, Biotech Stock Review

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.

“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”

Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.

Download Circle Group - Z-Trim Report

Latest article

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...